These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 7970631

  • 1. [Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study].
    Romics L, Karádi I, Csanády M, Gógl A, Jánosi A, Ofner P, Tarján J, Varga L, Wórum F, Zeltner G.
    Orv Hetil; 1994 Oct 02; 135(40):2187-91. PubMed ID: 7970631
    [Abstract] [Full Text] [Related]

  • 2. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
    Illingworth DR, Stein EA, Mitchel YB, Dujovne CA, Frost PH, Knopp RH, Tun P, Zupkis RV, Greguski RA.
    Arch Intern Med; 1994 Jul 25; 154(14):1586-95. PubMed ID: 8031206
    [Abstract] [Full Text] [Related]

  • 3. Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia.
    Itskovitz HD, Flamenbaum W, De Gaetano C, Pritchard KA, Stemerman MB.
    Clin Ther; 1989 Jul 25; 11(6):862-72. PubMed ID: 2611825
    [Abstract] [Full Text] [Related]

  • 4. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia].
    Catalán M, López de Ocáriz A, Alvarez MP, Ariño M, Azanza JR, Honorato J.
    Rev Med Univ Navarra; 1992 Jul 25; 37(3):127-33. PubMed ID: 1480917
    [Abstract] [Full Text] [Related]

  • 5. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
    März W, Grützmacher P, Paul D, Siekmeier R, Schoeppe W, Gross W.
    Int J Clin Pharmacol Ther; 1994 Feb 25; 32(2):92-7. PubMed ID: 8004365
    [Abstract] [Full Text] [Related]

  • 6. [Lovastatin efficacy and tolerance in primary hypercholesterolemia. The German Lovastatin Study Group].
    Thiery J, Basten A, Sommerburg C, Seidel D.
    Dtsch Med Wochenschr; 1991 Jun 07; 116(23):887-94. PubMed ID: 2040207
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of lovastatin in hypercholesterolemic women.
    D'Agostino RB, Kannel WB, Stepanians MN, D'Agostino LC.
    Clin Ther; 1992 Jun 07; 14(3):390-5. PubMed ID: 1638580
    [Abstract] [Full Text] [Related]

  • 8. [Lowering of the plasma lipid concentration with lovastatin. A clinical study in patients with primary hypercholesterolemia].
    Grüneberger S, Dreyer M, Kangah R, Reinicke A, Staisch C, Steinhagen-Thiessen E, Müller P, Simon B, Dammann HG.
    Dtsch Med Wochenschr; 1989 Nov 10; 114(45):1734-9. PubMed ID: 2806106
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun 10; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA, Grundy SM.
    Arch Intern Med; 1995 Feb 27; 155(4):393-9. PubMed ID: 7848022
    [Abstract] [Full Text] [Related]

  • 11. [Lovastatin in primary hypercholesterolemia. A Norwegian multicenter study].
    Ose L.
    Tidsskr Nor Laegeforen; 1992 Nov 30; 112(29):3665-9. PubMed ID: 1471127
    [Abstract] [Full Text] [Related]

  • 12. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects.
    Agrawal AR, Tandon M, Sharma PL.
    Int J Clin Pract; 2007 Nov 30; 61(11):1812-8. PubMed ID: 17935545
    [Abstract] [Full Text] [Related]

  • 13. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.
    Int J Clin Pharmacol Res; 2002 Nov 30; 22(3-4):89-99. PubMed ID: 12837046
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P, Walters EJ, Cullen EI, Niecestro R, Friedhoff LT.
    Curr Med Res Opin; 2004 Jan 30; 20(1):13-8. PubMed ID: 14741066
    [Abstract] [Full Text] [Related]

  • 15. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E, Aranda JL, Nogués X, del Palacio A, Rubiés-Prat J.
    Med Clin (Barc); 1996 May 25; 106(20):776-9. PubMed ID: 8801396
    [Abstract] [Full Text] [Related]

  • 16. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J, Hoffman R, Hanson M, Veltri E.
    Clin Ther; 2008 Dec 25; 30(12):2280-97. PubMed ID: 19167588
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.
    Clin Ther; 2007 Nov 25; 29(11):2365-73. PubMed ID: 18158077
    [Abstract] [Full Text] [Related]

  • 18. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
    Crespo N, Illnait J, Más R, Fernández L, Fernández J, Castaño G.
    Int J Clin Pharmacol Res; 1999 Nov 25; 19(4):117-27. PubMed ID: 10939029
    [Abstract] [Full Text] [Related]

  • 19. [Lovastatin. A new drug for the treatment of hypercholesterolemia].
    Abouganem D, Núñez P.
    Rev Med Panama; 1990 Sep 25; 15(3):184-96. PubMed ID: 2284448
    [Abstract] [Full Text] [Related]

  • 20. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 25; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.